iCardiac Revenue

Biotechnology Research • Philadelphia, Pennsylvania, United States • 21-50 Employees

iCardiac revenue & valuation

Annual revenue	$1,796,655
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$5,800,000
Total funding	No funding

Key Contacts at iCardiac

Chris Kingston

Senior Director, Business Development

Mike Reimringer

Director, Quality And Compliance

Company overview

Headquarters	1818 Market St, Philadelphia, Pennsylvania 19103, US
Websites	ert.com clario.com
NAICS	541714
Keywords	Consulting, Advanced Imaging, Respiratory Services, Spirometry, Cardiac Safety Services, Phase Ii-Iv Cardiac Safety, Phase I Qt Assessment, Tqt Studies, Centralized Trial Oversight, Electronic Clinical Outcome Assessments (Ecoa)
Founded	1997
Employees	21-50
Socials

iCardiac Email Formats

iCardiac uses 3 email formats. The most common is {first initial}.{last name} (e.g., j.doe@icardiac.com), used 55.6% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@icardiac.com	55.6%
{first name}.{last name}	john.doe@clario.com	44.4%

About iCardiac

iCardiac Technologies was acquired by ERT in December, 2017. ERT is a global data and technology company that minimizes uncertainty and risk in clinical trials so that our customers can move ahead with confidence. With nearly 50 years of clinical and therapeutic experience, we balance knowledge of what works with a vision for what’s next, so we can adapt without compromising standards. Powered by the company’s EXPERT® technology platform, our solutions enhance trial oversight, enable site optimization, increase patient engagement, and measure the efficacy of new clinical treatments while ensuring patient safety. Over the past four years, more than half of all FDA drug approvals came from ERT-supported studies. Pharma companies, Biotechs, and CROs have relied on ERT solutions in over 10,000 studies spanning more than three million patients to date. By identifying trial risks before they become problems, ERT enables customers to bring clinical treatments to patients quickly – and with confidence. Follow ERT and learn how you can accelerate clinical development with confidence.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Director

C-Suite

Employees by Department

iCardiac has 13 employees across 5 departments.

Departments

Number of employees

Funding Data

iCardiac has never raised funding before.

Frequently asked questions

iCardiac is located in Philadelphia, Pennsylvania, US.

iCardiac generates an estimated annual revenue of $1,796,655. This revenue figure reflects the company's market position and business performance in its industry.

iCardiac has an estimated valuation of $5,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

iCardiac was founded in 1997, making it 29 years old. The company has established itself as a significant player in its industry over this time.

iCardiac has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at iCardiac

Chris Kingston

Senior Director, Business Development

Mike Reimringer

Director, Quality And Compliance

4.8

40,000 users